Importance of Minimal Residual Disease

Presented in November 2021 at our New + Emerging Treatments Conference.

In this free virtual program for patients and caregivers, physician experts discussed the importance of minimal residual disease in the management of leukemia, lymphoma, myeloma, and MDS. The presentation is followed by a Q + A.


Celalettin Ustun, MD, Rush University Medical Center

Watch the video

Presentation slides